The Future of Therapeutics Begins Here
Northern Bio provides specialized preclinical research services, including in vivo non-GLP and GLP safety assessments and bioanalysis, to support regulatory approval of novel therapeutics.
30 Years of Targeted Delivery Expertise & Innovation
With over 30 years of experience in drug development, Northern Bio offers specialized preclinical research services. Our expertise focuses on a wide range of in vivo non-GLP and GLP safety assessment solutions for targeted delivery of novel therapeutics using advanced surgical techniques. Our Bioanalysis group specializes in advanced molecular biological techniques and ligand binding assays for the determination of biodistribution, persistence, and gene expression of next-generation therapeutics. Our scientific and regulatory teams collaborate closely with our clients to develop customized programs and individualized preclinical studies to facilitate regulatory approval.
Consult a Scientist
We are a team of scientists who value open communication and collaboration. We work closely with our sponsors to provide customized solutions and expert support.
Our Service Areas
Neuroscience
Partner With Us to advance your neuroscience program from early development to regulatory approval.
Ophthalmology
Partner With Us to advance your ophthalmology program from early development to regulatory approval.
Cardiovascular
Partner With Us to advance your cardiovascular therapeutic from early development to regulatory approval.
Metabolic
Partner With Us to expedite your metabolic therapeutics from early development to regulatory approval.
Rare Disease
Partner With Us to accelerate the development of your therapeutic from early development to regulatory approval.
Surgical Models
Partner With Us when choosing the appropriate surgical model to evaluate your therapeutic.
Our Bioanalytical Services
Northern Bio offers customized and comprehensive molecular biology services, ligand binding assays, and biomarker assays to support all phases of the development of next-generation therapeutics. We work scientist to scientist, collaborating with our clients to develop molecular biology and bioanalytical solutions to expedite development of novel therapeutics.
Bioanalytical Capabilities
Northern Bio utilizes molecular and immunoassay platforms, such as real-time PCR and qPCR, to develop and validate assays that evaluate biodistribution and persistence of gene and cell therapies.
Bioanalytical Instrumentation
Northern Bio has multiple instruments for molecular assays including QuantStudio 7 Flex Real Time PCR and QIAcuity One & Four, and for ligand binding assays and biomarkers, including Meso Sector 600MM and Spectramax iD5.
Partner With Us
Let’s work together to develop
life-changing treatments.
Join us in the pursuit of better lives through scientific innovation. Explore how Northern Bio can help you achieve your research goals.